Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | ADH1B | P00325 | 1/20 | 0.58 |
| ▸ | ADH1C | P00326 | 1/20 | 0.58 |
| ▸ | ADH1A | P07327 | 1/20 | 0.58 |
| ▸ | ADH7 | P40394 | 1/20 | 0.58 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15607673 | 0.85 | MEN1 (0.64) | MEN1KMT2ATDP1ADH1BADH1C | |
| SCHEMBL4865476 | 0.81 | SMN1; SMN2 (0.43) | MEN1KMT2ATDP1ADH1BADH1C | |
| SCHEMBL27625443 | 0.79 | MEN1 (0.56) | MEN1KMT2ATDP1ADH1BADH1C | |
| SCHEMBL27686314 | 0.79 | MEN1 (0.56) | MEN1KMT2ATDP1ADH1BADH1C | |
| SCHEMBL681149 | 0.79 | MEN1 (0.56) | MEN1KMT2ATDP1ADH1BADH1C | |
| SCHEMBL1654 | 0.79 | MEN1 (0.78) | MEN1KMT2ATDP1ADH1BADH1C | |
| Benzene SCHEMBL11697595 | 0.79 | MEN1 (0.78) | MEN1KMT2ATDP1ADH1BADH1C | |
| SCHEMBL5799878 | 0.79 | MEN1 (0.78) | MEN1KMT2ATDP1ADH1BADH1C | |
| SCHEMBL14269470 | 0.77 | LMNA (0.55) | MEN1KMT2ADPP7CHRM2CA2 | |
| SCHEMBL21414853 | 0.77 | CHRM2 (0.53) | MEN1KMT2ATDP1CHRM2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012164476-A1 | NEW TRICYCLIC COMPOUNDS, PROCESS FOR THEIR MANUFACTURE AND THEIR USE AS LIGANDS OF THE BETA AMYLOID PEPTIDES | UNIVERSITÀ DEGLI STUDIO DI MILANO - BICOCCA (IT) | 2012-12-06 | — | — | WO | claimed |
| CN-102015993-A | Encapsulated benefit agent | UNILEVER PLC | 2011-04-13 | — | — | CN | claimed |
| EP-2044083-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2009-04-08 | — | — | EP | claimed |
| US-20080051384-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. | 2008-02-28 | — | — | US | claimed |
| WO-2008008907-A2 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | claimed |
| WO-2008008912-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | claimed |
| US-20060211698-A1 | Bicyclic heteroaryl derivatives for treating viruses | GENELABS, INC. | 2006-09-21 | — | — | US | claimed |
| JP-11276808-A | — | — | None | — | — | JP | disclosed |
| US-20240240062-A1 | (METH)ACRYLATE-BASED TWO-PART ADHESIVE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2024-07-18 | — | — | US | disclosed |
| CN-118043422-A | Two-part adhesive compositions based on (meth) acrylic esters | 汉高股份有限及两合公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2023106896-A1 | NOVEL ADIPONECTIN-DERIVED PEPTOID DERIVATIVE AND USE THEREOF | 서울대학교병원 | 2023-06-15 | — | — | WO | disclosed |
| WO-2023050111-A1 | (METH) ACRYLATE-BASED TWO-PART ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2023-04-06 | — | — | WO | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-20030232391-A1 | Identification of kinase inhibitors | SUNESIS PHARMACEUTICALS, INC. | 2003-12-18 | — | — | US | disclosed |
| WO-2003087204-A1 | CURABLE FOAM ELASTOMERIC COMPOSITIONS | HENKEL CORPORATION (US) | 2003-10-23 | — | — | WO | disclosed |
| EP-1337853-A2 | AN EXTENDED TETHERING APPROACH FOR RAPID IDENTIFICATION OF LIGANDS | Sunesis Pharmaceuticals, Inc. (US) | 2003-08-27 | — | — | EP | disclosed |
| US-20020150947-A1 | Extended tethering approach for rapid identification of ligands | SUNESIS PHARMACEUTICALS, INC. | 2002-10-17 | — | — | US | disclosed |
| WO-2002042773-A2 | AN EXTENDED TETHERING APPROACH FOR RAPID IDENTIFICATION OF LIGANDS | SUNESIS PHARMACEUTICALS, INC. (US) | 2002-05-30 | — | — | WO | disclosed |
| JP-H11276808-A | DEHYDRATING AGENT FOR FILTER PRESS AND DEHYDRATION | HYMO CORP | 1999-10-12 | — | — | JP | disclosed |
| EP-0178381-A2 | Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents | USV PHARMACEUTICAL CORPORATION (US) | 1986-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211698-A1 | Bicyclic heteroaryl derivatives for treating viruses | HAVCR2, ZC3HAV1, SARS1 | MEN1 4103/4885KMT2A 2460/4885TDP1 2016/4885 |
| US-20080051384-A1 | ANTIVIRAL AGENTS | EIF2AK2, MAVS, ZC3HAV1 | MEN1 4834/4885KMT2A 4254/4885TDP1 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.